Take Your Trading To The Next Level. Get Started Here!
+1 (949) 514 8188
The obesity approval further establishes Eli Lilly as a formidable competitor to Novo Nordisk in the budding weight loss drug industry.
FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drug
The obesity approval further establishes Eli Lilly as a formidable competitor to Novo Nordisk in the budding weight loss drug industry.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender